Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection

JAMA Intern Med. 2014 Jun;174(6):1003-5. doi: 10.1001/jamainternmed.2014.1175.

Authors

Stefan Lüth¹, Thorben W Fründt¹, Thomas Rösch², Christoph Schlee¹, Ansgar W Lohse¹

Affiliations

¹ Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
² Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

PMID: 24781800
DOI: 10.1001/jamainternmed.2014.1175

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Enterohemorrhagic Escherichia coli*
Escherichia coli Infections / complications*
Escherichia coli Infections / microbiology
Escherichia coli Infections / therapy
Female
Hemolytic-Uremic Syndrome / microbiology
Hemolytic-Uremic Syndrome / prevention & control*
Humans
Male
Middle Aged
Polyethylene Glycols / administration & dosage*
Retrospective Studies
Surface-Active Agents / administration & dosage*
Therapeutic Irrigation
Young Adult

Substances

Surface-Active Agents
Polyethylene Glycols